Andreas Kovar

1.4k total citations
27 papers, 1.0k citations indexed

About

Andreas Kovar is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Andreas Kovar has authored 27 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 5 papers in Pediatrics, Perinatology and Child Health and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Andreas Kovar's work include HER2/EGFR in Cancer Research (5 papers), Cell Adhesion Molecules Research (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Andreas Kovar is often cited by papers focused on HER2/EGFR in Cancer Research (5 papers), Cell Adhesion Molecules Research (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Andreas Kovar collaborates with scholars based in Germany, United States and France. Andreas Kovar's co-authors include Bernd Meibohm, Manish Gupta, Arno Nolting, Wolfgang Uhl, Teresa Dalla Costa, Oliver Rosen, José Baselga, Hartmut Derendorf, U. Vanhoefer and Federico Rojo and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Cancer Research.

In The Last Decade

Andreas Kovar

26 papers receiving 988 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Kovar Germany 15 447 258 220 187 126 27 1.0k
Diane D. Wang United States 14 372 0.8× 191 0.7× 154 0.7× 115 0.6× 126 1.0× 29 825
Akintunde Bello United States 21 891 2.0× 444 1.7× 582 2.6× 112 0.6× 235 1.9× 71 1.7k
Τushar Garimella United States 17 241 0.5× 198 0.8× 180 0.8× 52 0.3× 36 0.3× 44 1.4k
Brian P. Monahan United States 12 295 0.7× 245 0.9× 108 0.5× 54 0.3× 98 0.8× 22 931
Jan Gerard Maring Netherlands 20 794 1.8× 563 2.2× 193 0.9× 33 0.2× 69 0.5× 41 1.3k
Joanne Davis United States 22 338 0.8× 576 2.2× 402 1.8× 126 0.7× 36 0.3× 35 1.7k
Dominique Werner Switzerland 21 373 0.8× 427 1.7× 363 1.6× 121 0.6× 38 0.3× 49 1.3k
Arno Nolting United States 15 304 0.7× 265 1.0× 244 1.1× 74 0.4× 32 0.3× 28 898
Luis López Lázaro Spain 25 401 0.9× 430 1.7× 419 1.9× 31 0.2× 91 0.7× 63 1.6k
Gabriele Kirchner Germany 25 366 0.8× 356 1.4× 136 0.6× 87 0.5× 119 0.9× 54 2.0k

Countries citing papers authored by Andreas Kovar

Since Specialization
Citations

This map shows the geographic impact of Andreas Kovar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Kovar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Kovar more than expected).

Fields of papers citing papers by Andreas Kovar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Kovar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Kovar. The network helps show where Andreas Kovar may publish in the future.

Co-authorship network of co-authors of Andreas Kovar

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Kovar. A scholar is included among the top collaborators of Andreas Kovar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Kovar. Andreas Kovar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nassr, Nassr, Faı̈za Rharbaoui, Dietmar Weitz, et al.. (2025). First‐in‐Human Single and Multiple Ascending Dose Studies of Balinatunfib, a Small Molecule Inhibitor of TNFR1 Signaling in Healthy Participants. Clinical Pharmacology & Therapeutics. 118(1). 164–176.
2.
Kovar, Andreas, et al.. (2023). Sutimlimab Pharmacokinetics and Pharmacodynamics in Patients with Cold Agglutinin Disease. Journal of Pharmacology and Experimental Therapeutics. 386(2). 143–155. 2 indexed citations
3.
Lippert, Jörg, Rolf Burghaus, Andrea N. Edginton, et al.. (2019). Open Systems Pharmacology Community—An Open Access, Open Source, Open Science Approach to Modeling and Simulation in Pharmaceutical Sciences. CPT Pharmacometrics & Systems Pharmacology. 8(12). 878–882. 78 indexed citations
4.
Uhl, Wolfgang, M. Zühlsdorf, Thomas Koernicke, Ulf Forssmann, & Andreas Kovar. (2013). Safety, tolerability, and pharmacokinetics of the novel αv-integrin antibody EMD 525797 (DI17E6) in healthy subjects after ascending single intravenous doses. Investigational New Drugs. 32(2). 347–354. 21 indexed citations
5.
Budha, Nageshwar, Andreas Kovar, & Bernd Meibohm. (2011). Comparative Performance of Cell Life Span and Cell Transit Models for Describing Erythropoietic Drug Effects. The AAPS Journal. 13(4). 650–661. 8 indexed citations
6.
7.
Kovar, Andreas, et al.. (2009). Refinement of the Population Pharmacokinetic Model for the Monoclonal Antibody Matuzumab. Clinical Pharmacokinetics. 48(7). 477–487. 8 indexed citations
8.
Ribas, Antoni, John M. Kirkwood, Michael B. Atkins, et al.. (2009). Phase I/II open-label study of the biologic effects of the interleukin-2 immunocytokine EMD 273063 (hu14.18-IL2) in patients with metastatic malignant melanoma. Journal of Translational Medicine. 7(1). 68–68. 36 indexed citations
9.
10.
Krösser, Sonja, et al.. (2007). Investigation of the impact of sarizotan on the pharmacokinetics of levodopa. Biopharmaceutics & Drug Disposition. 28(7). 339–347. 9 indexed citations
11.
Uhl, Wolfgang, Arno Nolting, Georg Golor, Karl Ludwig Rost, & Andreas Kovar. (2006). Safety of Hydroxocobalamin in Healthy Volunteers in a Randomized, Placebo-Controlled Study. Clinical Toxicology. 44(sup1). 17–28. 71 indexed citations
12.
Krösser, Sonja, et al.. (2006). Investigation of sarizotan’s impact on the pharmacokinetics of probe drugs for major cytochrome P450 isoenzymes: a combined cocktail trial. European Journal of Clinical Pharmacology. 62(4). 277–284. 23 indexed citations
13.
Bhattaram, Venkatesh Atul, N. Nagaraja, Tanja Peters, et al.. (2005). Population Pharmacokinetics of Eniporide and Its Metabolite in Healthy Subjects and Patients With Acute Myocardial Infarction. The Journal of Clinical Pharmacology. 45(6). 631–639. 2 indexed citations
14.
Delbaldo, Catherine, Jean‐Yves Pierga, Véronique Dièras, et al.. (2005). Pharmacokinetic profile of cetuximab (Erbitux™) alone and in combination with irinotecan in patients with advanced EGFR-positive adenocarcinoma. European Journal of Cancer. 41(12). 1739–1745. 71 indexed citations
15.
Gupta, Manish, Andreas Kovar, & Bernd Meibohm. (2005). The Clinical Pharmacokinetics of Phosphodiesterase‐5 Inhibitors for Erectile Dysfunction. The Journal of Clinical Pharmacology. 45(9). 987–1003. 142 indexed citations
16.
Ko, Yoo‐Joung, Glenn J. Bubley, Robert Weber, et al.. (2004). Safety, Pharmacokinetics, and Biological Pharmacodynamics of the Immunocytokine EMD 273066 (huKS-IL2). Journal of Immunotherapy. 27(3). 232–239. 52 indexed citations
17.
Kovar, Andreas, Tanja Peters, Norbert Beier, & Hartmut Derendorf. (2001). Pharmacokinetic/Pharmacodynamic Evaluation of the NHE Inhibitor Eniporide. The Journal of Clinical Pharmacology. 41(2). 139–148. 9 indexed citations
18.
Bier, H., Thomas K. Hoffmann, U. Häuser, et al.. (2001). Clinical trial with escalating doses of the antiepidermal growth factor receptor humanized monoclonal antibody EMD 72 000 in patients with advanced squamous cell carcinoma of the larynx and hypopharynx. Cancer Chemotherapy and Pharmacology. 47(6). 519–524. 67 indexed citations
19.
Kovar, Andreas, Teresa Dalla Costa, & Hartmut Derendorf. (1997). Comparison of Plasma and Free Tissue Levels of Ceftriaxone in Rats by Microdialysis. Journal of Pharmaceutical Sciences. 86(1). 52–56. 50 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Diane D. Wang Breakdown of academic impact, for papers by Akintunde Bello Breakdown of academic impact, for papers by Τushar Garimella Breakdown of academic impact, for papers by Brian P. Monahan Breakdown of academic impact, for papers by Jan Gerard Maring Breakdown of academic impact, for papers by Joanne Davis Breakdown of academic impact, for papers by Dominique Werner Breakdown of academic impact, for papers by Arno Nolting Breakdown of academic impact, for papers by Luis López Lázaro Breakdown of academic impact, for papers by Gabriele Kirchner
Rankless by CCL
2026